Brigit Biofarmaka Teknologi Tbk. vs Tunas Baru Lampung Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Tunas Baru Lampung Tbk. trades at Rp645 (market cap 3.89T, 1.12M 24h volume). The key difference: Tunas Baru Lampung Tbk. is far larger — about 22.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Tunas Baru Lampung Tbk. is more actively traded (1.12M versus 218.7K). Which is the better fit depends on your goals.
| OBAT | TBLA | |
|---|---|---|
Market Cap | 172.82B | 3.89T |
Volume | 218.7K | 1.12M |
Lot | 2.19K | 11.22K |
Turnover | 53.51M | 723.81M |
Average Price | 244.66 | 645.4 |
Value | 53.51M | 723.81M |
Indicative Equilibrium Price | 252 | 645 |
Indicative Equilibrium Volume | 48 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Tunas Baru Lampung Tbk (the Company) was established by virtue of Notarial Deed No. 23 dated December 22, 1973 of Halim Kurniawan, S.H., public notary in Teluk Betung. PT. Tunas Baru Lampung is a member of Sungai Budi Group which was founded in 1947 and is a pioneer in Indonesia`s agricultural industry.
Read more on TBLA →